Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disorders.

Abstract

Primary antithrombotic prevention with aspirin is not indicated in asymptomatic patients with confirmed antiphospholipid (aPL) positivity without systemic autoimmune disorders because: a) the estimated prevalence of thrombosis in unselected cases is about 1% patient-years (range 0-2.8); b) this level of thrombotic risk is equivalent to that of major… (More)
DOI: 10.1177/0961203312437440

Topics

Cite this paper

@article{Finazzi2012PrimaryAP, title={Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disorders.}, author={Guido Finazzi}, journal={Lupus}, year={2012}, volume={21 7}, pages={747-50} }